Tment; Lv = value of a death averted; Dmort = Disease mortality; 1379592 t = test HIV-RT inhibitor 1 threshold; tT test/treatment threshold; tc = test cost; FP = false AKT inhibitor 2 manufacturer positive rate; TP = true positive rate; FN = false negative rate; TN = true negative rate; Tb = Treatment burden ( = Tc +Tmort * Lv); Db = Disease burden ( = Dmort * Lv). doi:10.1371/journal.pone.0058019.tSupporting 
InformationMethods S1 variables. x = diseased; 1-x = not diseased; Tc = Treatment cost; Tmort = mortality caused by the treatment; Lv = value of a death averted; Dmort = Disease mortality; t = test 
threshold; tT test/treatment threshold; tc = test cost; FP = false positive rate; TP = true positive rate; FN = false negative rate; TN = true negative rate; Tb = Treatment burden ( = Tc +Tmort * Lv); Db = Disease burden ( = Dmort * Lv). (DOC) Results Srate; FN = false negative rate; TN = true negative rate; Tb = Treatment burden ( = Tc +Tmort * Lv); Db = Disease burden ( = Dmort * Lv). (DOC)Author ContributionsCritically discussed the study design: HT BSS FG AA DB. Retrieved relevant literature: DB. Substantially improved the first draft: DB JVdE. Substantially contributed to previous published field studies providing baseline data for this research: HT BSS FG AA. Conceived and designed the experiments: ZB JVdE. Performed the experiments: ZB JVdE. Analyzed the data: ZB JVdE. Wrote the paper: ZB HT BSS FG AA DB JVdE.variables Tc = Treatment cost; Tmort = mortality caused by the treatment; Lv = value of a death averted; Dmort = Disease mortality; t = test threshold; tT test/treatment threshold; tc = test cost; FP = false positive rate; TP = true positive
Despite the important role of electro-mechanical alternans in cardiac arrhythmogenesis [1], [2], its molecular origin is not well understood. This phenomenon has been associated with alternation in both ionic currents and in the cytosolic calcium transient. The latter has been linked to a dysfunction of sarcoplasmic reticulum (SR) calcium uptake [3], [4], or release [4], [5], [6], [7]. Indeed, several reports [5], [7] seem to support the hypothesis that the origin of alternans could lie in a steep relationship between SR calcium load and calcium release [4]. This steep relation has been explained as a dependence of the operating state of the ryanodine receptor (RyR2) with the SR calcium bound to calsequestrin [8], thus implying a stronger release at high calcium loads. Nevertheless, cytosolic calcium alternans has been observed both in the absence and presence of concurrent fluctuations in SR calcium loading [9], [10], [11]. Recently, Shkryl et al [11] have confirmed the presence of alternans without SR calciumfluctuations and related it to incomplete recovery in refractoriness of SR calcium release. This suggests that, besides calcium loading, other properties of the SR, such as activation of the ryanodine receptor (RyR2) [5], [6], inactivation of the RyR2 [12], [13], recovery of the RyR2 from inactivation [12], [14], and termination of calcium release through the RyR2 [15], [16], may all intervene in the regulation of the beat-to-beat stability of the cytosolic calcium transient. To address this issue, a major challenge lies in the difficulty of using experimental animal or cell models to resolve the specific contribution of a single property of the SR to the calcium transient and its beat-to-beat stability. Most often, manipulation of one parameter affects the state of several others, thus hampering quantification of its specific contributio.Tment; Lv = value of a death averted; Dmort = Disease mortality; 1379592 t = test threshold; tT test/treatment threshold; tc = test cost; FP = false positive rate; TP = true positive rate; FN = false negative rate; TN = true negative rate; Tb = Treatment burden ( = Tc +Tmort * Lv); Db = Disease burden ( = Dmort * Lv). doi:10.1371/journal.pone.0058019.tSupporting InformationMethods S1 variables. x = diseased; 1-x = not diseased; Tc = Treatment cost; Tmort = mortality caused by the treatment; Lv = value of a death averted; Dmort = Disease mortality; t = test threshold; tT test/treatment threshold; tc = test cost; FP = false positive rate; TP = true positive rate; FN = false negative rate; TN = true negative rate; Tb = Treatment burden ( = Tc +Tmort * Lv); Db = Disease burden ( = Dmort * Lv). (DOC) Results Srate; FN = false negative rate; TN = true negative rate; Tb = Treatment burden ( = Tc +Tmort * Lv); Db = Disease burden ( = Dmort * Lv). (DOC)Author ContributionsCritically discussed the study design: HT BSS FG AA DB. Retrieved relevant literature: DB. Substantially improved the first draft: DB JVdE. Substantially contributed to previous published field studies providing baseline data for this research: HT BSS FG AA. Conceived and designed the experiments: ZB JVdE. Performed the experiments: ZB JVdE. Analyzed the data: ZB JVdE. Wrote the paper: ZB HT BSS FG AA DB JVdE.variables Tc = Treatment cost; Tmort = mortality caused by the treatment; Lv = value of a death averted; Dmort = Disease mortality; t = test threshold; tT test/treatment threshold; tc = test cost; FP = false positive rate; TP = true positive
Despite the important role of electro-mechanical alternans in cardiac arrhythmogenesis [1], [2], its molecular origin is not well understood. This phenomenon has been associated with alternation in both ionic currents and in the cytosolic calcium transient. The latter has been linked to a dysfunction of sarcoplasmic reticulum (SR) calcium uptake [3], [4], or release [4], [5], [6], [7]. Indeed, several reports [5], [7] seem to support the hypothesis that the origin of alternans could lie in a steep relationship between SR calcium load and calcium release [4]. This steep relation has been explained as a dependence of the operating state of the ryanodine receptor (RyR2) with the SR calcium bound to calsequestrin [8], thus implying a stronger release at high calcium loads. Nevertheless, cytosolic calcium alternans has been observed both in the absence and presence of concurrent fluctuations in SR calcium loading [9], [10], [11]. Recently, Shkryl et al [11] have confirmed the presence of alternans without SR calciumfluctuations and related it to incomplete recovery in refractoriness of SR calcium release. This suggests that, besides calcium loading, other properties of the SR, such as activation of the ryanodine receptor (RyR2) [5], [6], inactivation of the RyR2 [12], [13], recovery of the RyR2 from inactivation [12], [14], and termination of calcium release through the RyR2 [15], [16], may all intervene in the regulation of the beat-to-beat stability of the cytosolic calcium transient. To address this issue, a major challenge lies in the difficulty of using experimental animal or cell models to resolve the specific contribution of a single property of the SR to the calcium transient and its beat-to-beat stability. Most often, manipulation of one parameter affects the state of several others, thus hampering quantification of its specific contributio.
